-
Mashup Score: 0Testing guidelines during times of crisis: challenges and limitations of developing rapid and living guidelines - 1 year(s) ago
The start of the COVID-19 pandemic presented a situation in which there was an urgent need for decision-making that relates to diagnosis, but the evidence was lacking, of low certainty or constantly changing. Rapid and living guideline development methods were needed and had to be applied to rigorous guideline approaches, such as the Grading of Recommendations Assessment, Development, and…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 111Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19 - 1 year(s) ago
Managing the COVID-19 pandemic has required the implementation of public health mitigation measures to limit the transmission of SARS-CoV-2. Airborne transmission via particles of different sizes, generally called droplets and aerosols, was recognized very late by Public Health organizations in part due to limited direct evidence of infectious virus in air samples. SARS-CoV-2 RNA has been…
Categories: Healthcare Professionals, Latest HeadlinesTweet-
Longtime bioaerosol group Duchaine detected viable SARS-CoV-2 using a condensation sampler (SPOT) in hospital air. 41% of filter samples & 25% of SPOT samples positive by qRT-PCR, and airborne concentrations were 129-2056 gc/m3. https://t.co/TWAzAFP9RK
-
-
Mashup Score: 10Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19 - 1 year(s) ago
Managing the COVID-19 pandemic has required the implementation of public health mitigation measures to limit the transmission of SARS-CoV-2. Airborne transmission via particles of different sizes, generally called droplets and aerosols, was recognized very late by Public Health organizations in part due to limited direct evidence of infectious virus in air samples. SARS-CoV-2 RNA has been…
Categories: Infectious Disease, Latest HeadlinesTweet-
Very nice new study “proving” viable sars2 virus in bioaerosols Of course, this was obvious as soon as the 1st superspreader events happened Many scientists were yelling it Took far too long to be accepted by public health agencies & impact policy https://t.co/s8cwqZHb0W
-
-
Mashup Score: 6
Cytomegalovirus is an opportunistic pathogen responsible for substantial morbidity after solid organ transplantation and hematopoietic stem cell transplantation. Treatment of CMV disease involves a two-pronged approach with antiviral drug treatment coupled with strategies to minimize the intensity of immune suppression.
Categories: Hem/Oncs, Latest HeadlinesTweet-
RT @LeonardLeibovi1: Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients https://t.co/JIQSACnIBU
-
-
Mashup Score: 0Zoonotic spill-over of SARS-CoV-2: mink-adapted virus in humans - 1 year(s) ago
This work aimed to analyse possible zoonotic spill-over of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report the spill-over of mink-adapted SARS-CoV-2 from farmed mink to humans after adaptation that lasted at least 3 months.
Categories: Infectious Disease, Latest HeadlinesTweet-
RT @k_pyrc: @MarionKoopmans @EC_HERA Yep. https://t.co/GM4DUIoBeg
-
-
Mashup Score: 48
Post-acute coronavirus 2019 (COVID-19) syndrome (PACS) is a well-recognized complex systemic disease that is associated with substantial morbidity. There is a paucity of established interventions to treat patients with this syndrome.
Categories: Expert Picks, Latest HeadlinesTweet-
A long hunt for a #LongCovid validated treatment, for which there are none yet A review of 388 registered clinical trials assessing 144 different interventions. Many candidates, as we recently reviewed, but trials are too small, equivocal https://t.co/TRg8r8o0C5 @CMIJournal https://t.co/rMIrYedI3M
-
-
Mashup Score: 2
Post-acute coronavirus 2019 (COVID-19) syndrome (PACS) is a well-recognized complex systemic disease that is associated with substantial morbidity. There is a paucity of established interventions to treat patients with this syndrome.
Categories: Infectious Disease, Latest HeadlinesTweet-
388 registered clinical trials for post acute covid 19 syndrome . Lets hope this will bring some progress https://t.co/hsC10KvM4l
-
-
Mashup Score: 2Mass drug administration of azithromycin: an analysis - 2 year(s) ago
The World Health Organization recommends mass drug administration (MDA) of the antibiotic azithromycin for children 1-11 months of age in areas with high infant and child mortality. Notwithstanding the substantial potential benefits in lowering childhood mortality, MDA raises understandable concerns about exacerbating antibiotic resistance.
Categories: Infectious Disease, Latest HeadlinesTweet-
Mass drug administration of azithromycin: an analysis - Clinical Microbiology and Infection. Just out led by @rebeccajk13 with Samba Sow and Nir Eyal https://t.co/EPl44i8WKG
-
-
Mashup Score: 0
Emerging infectious diseases are a growing threat, through population growth, increased trade and travel, urbanization, deforestation, and climate change [1]. Clinical research in response to emerging infectious diseases is challenging; selecting and contracting the appropriate study sites for a trial is time consuming, and often too few patients can be timely recruited to acquire high-quality…
Categories: Infectious Disease, Latest HeadlinesTweet-
development of permanent observational studies to prepare hospitals for clinical research on emerging diseases https://t.co/K69BymZfE1 @Ecraid https://t.co/3V7S62s9aK
-
-
Mashup Score: 4
Prognostic models are typically developed to estimate the risk that an individual in a particular health state will develop a particular health outcome, to support (shared) decision making. Systematic reviews of prognostic model studies can help identify prognostic models that need to further be validated or are ready to be implemented in healthcare.
Categories: Hem/Oncs, Latest HeadlinesTweet-
How to conduct a systematic review and meta-analysis of prognostic model studies https://t.co/puMdk8szz7 via @MaartenvSmeden et al @Argenscore @VictorDayan1 @pomyers @ovidiogarciav @mmamas1973 @dr_benoy_n_shah @MadalinaGarbi @SABOURETCardio https://t.co/VLJJPcHdiA
-
RT @pash22: How to conduct a systematic review and meta-analysis of prognostic model studies https://t.co/puMdk8szz7 via @MaartenvSmeden et…
-
Testing guidelines during times of crisis: challenges and limitations of developing rapid and living guidelines https://t.co/r17Iw2ayjL via @ibrahimelmikati & @Reem_A_Mustafa et al